HHS Releases Much Awaited Final 340B Rule, Sets Fines for Noncompliant Manufacturers
January 5th 2017The Health Resources and Services Administration (HRSA) within HHS has finalized a rule for all drug manufacturers who are required to make their drugs available to covered care providers under the 340B drug pricing program.
Read More
Reducing Radiation Dose in Oropharynx Cancer Can Improve QOL
December 28th 2016A new clinical study to reduce the unwanted side effects of radiation in patients with human papillomavirus (HPV)—positive oropharynx cancers has found that reducing the dose of radiation can maintain the cure rates but avoid some of the late treatment-associated toxicities.
Read More
NYSHealth's Report Finds Market Leverage Controls Hospital Pricing
December 21st 2016Wide price variation in hospital prices for the care that they render-up to a 2.7-fold difference-is driven by the hospital's market leverage, according to a new report by the New York State Health Foundation (NYSHealth).
Read More
Employers Express Their Concerns With Cancer Care at the COA Summit
December 19th 2016At the Community Oncology Alliance (COA) Payer Exchange Summit V, 2 employer groups and a provider participated on a panel to provide practical insight into the extraordinary challenges and decisions that employers and employees with a cancer diagnosis are faced with.
Read More
Will a Payer-Provider Collaboration Guarantee OCM Success?
December 19th 2016At the Payer Exchange Summit V, in Tyson’s Corner, Virginia, oncologists and payers came together to discuss the role of collaboration and data sharing for the successful implementation of the Oncology Care Model (OCM).
Read More
How Can Practices Seek Success With Oncology Payment Reform?
December 15th 2016Bruce Gould, MD, president and medical director, Northwest Georgia Oncology Center, and president of the Community Oncology Alliance, presented an overview of how cancer care has improved over the years and what the current challenges are.
Read More
AARP Report: Prescription Drug Prices Maintained an Upward Trajectory in 2015
December 15th 2016The Rx Price Watch report from the Public Policy Institute of the American Association of Retired Persons (AARP) has found that retail prices of widely used brand name prescription drugs rose at a significantly faster rate than general inflation over the past decade.
Read More
Second Scalp Cooling Device to Prevent Chemotherapy-Induced Alopecia Seeks FDA Approval
December 15th 2016Paxman is seeking approval for using its scalp cooling device as an intervention to prevent chemotherapy-induced alopecia (CIA) in women undergoing chemotherapy treatment for breast cancer.
Read More
NIH-Funded Survey Reports Decline in Vaping and Use of Hookahs, Cigarettes by Teens
December 14th 2016A survey funded by the National Institutes of Health (NIH)’s National Institute on Drug Abuse has found that vaping, cigarette smoking, and use of hookahs among adolescents has declined over the past year.
Read More
Preventing Chemotherapy-Associated Alopecia: A Case for Palliation?
December 14th 2016Chemotherapy-associated alopecia, which drastically changes how a person looks and feels, can significantly impact the patient’s quality of life, over and above the physical exhaustion associated with their treatment. Raising awareness among providers, patients, and their caregivers can help.
Read More
FDA Reaffirms Bladder Cancer Risk With Use of Pioglitazone
December 13th 2016The FDA has released an updated safety announcement following a fresh review of data on the type 2 diabetes treatment pioglitazon to confirm that the drug may increase a person’s likelihood of developing bladder cancer.
Read More
Social Ties Significantly Impact Survival of Patients With Breast Cancer
December 12th 2016An exhaustive study conducted by researchers at the Kaiser Permanente Division of Research has found that a woman’s social network can significantly affect her chances of survival following breast cancer.
Read More